Cancer
Scientists at the Institute for Cancer Research and Treatment (IRCCS) Santa Lucia Foundation in Rome, Italy, have published a seminal paper exploring the transformative impact of genomics and artificial intelligence (AI) in precision oncology. According to the research, the increasing burden of cancer globally necessitates innovative approaches for diagnosis, prognosis,
Cancer
Researchers at the Dana-Farber Cancer Institute have made significant discoveries in the field of Waldenstrom macroglobulinemia, a rare blood disorder. According to a new report, mutations in MYD88 (95%-97%) and CXCR4 (30%-40%) are common in patients with WM. The study, supported by the International Waldenstrom's Macroglobulinemia
Cancer
The NHS is piloting a new way to prevent oesophageal cancer by offering a non-invasive "sponge on a string" test in high-street pharmacies. The test is designed to detect a condition called Barrett's oesophagus, which occurs when stomach acid damages the lining of the oesophagus, increasing
Cancer
The National Health Service (NHS) in England is launching a pilot program to offer a non-invasive "sponge on a string" test to individuals with persistent heartburn or acid reflux at high-street pharmacies. This innovative approach aims to detect Barrett's oesophagus, a condition that can develop into
Cancer
Scientists at The Wistar Institute have made a significant discovery about the mechanisms by which the Epstein-Barr virus (EBV) reprograms B cells to facilitate cancer development. EBV, which infects over 90% of the world's population, typically causes mild or no symptoms but can lead to serious diseases, including
Cancer
Despite significant advances in treating multiple myeloma, older patients, males, and those from underrepresented racial and ethnic groups continue to face disparate survival rates. Research published in the British Journal of Haematology tracked the survival rates of 50,288 adults diagnosed with multiple myeloma between 2000 and 2019. The study
Cancer
In a recent study published in the Lancet Oncology, researchers at the Cleveland Clinic Foundation found that the combination of enfortumab vedotin plus pembrolizumab significantly improved survival outcomes for patients with previously untreated locally advanced or metastatic urothelial cancer. The study, which enrolled 886 patients, found that the treatment combination
Cancer
Researchers from Guangxi Normal University have made significant strides in cancer gene therapy, developing a high-efficacy and low-toxicity cobalt(II) agent capable of targeting and inhibiting tumor growth. This innovative approach leverages the tumor microenvironment and liposomes to deliver the cobalt(II) complex, C3, which has shown impressive cytotoxicity against
Cancer
A recent research study has shed new light on the multifaceted role of glutathione (GSH) in cancer biology and therapeutic interventions. According to the study, GSH plays an essential role in maintaining redox balance, mitigating oxidative stress, and preserving cellular homeostasis. Furthermore, GSH serves as a critical regulator of ferroptosis,
Cancer
Cancer therapy has advanced significantly in recent years, with researchers identifying new targets for treatment. A recent study from Yale University has highlighted the importance of targeting Polo-like kinase 4 (PLK4), a serine-threonine kinase involved in centrosome duplication. The study, published in Cancer and Metastasis Reviews, discusses the role of
Cancer
Aldi's dedication to helping young people affected by cancer has led to a significant milestone in its partnership with the Teenage Cancer Trust, raising £12 million since 2017. This achievement is a result of the supermarket's customers and staff coming together to support the charity'
Cancer
Researchers at the University of Chicago have developed a novel liquid biopsy technology that uses RNA to detect cancer, achieving an unprecedented accuracy rate of 95% in identifying early colorectal cancer. This innovative method surpasses existing non-invasive detection methods, which have an accuracy rate of around 90% for late-stage cancer
